Results 11 to 20 of about 25,762 (279)

Atypical hemolytic-uremic syndrome [PDF]

open access: yesDefinitions, 2020
Atypical hemolytic-uremic syndrome is a disease that primarily affects kidney function. This condition, which can occur at any age, causes abnormal blood clots (thrombi) to form in small blood vessels in the kidneys. These clots can cause serious medical

semanticscholar   +4 more sources

Atypical hemolytic uremic syndrome [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2011
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non Shiga-toxin-HUS and even if some authors include secondary aHUS due to Streptococcus pneumoniae
Frémeaux-Bacchi Véronique   +1 more
doaj   +3 more sources

Atypical hemolytic uremic syndrome [PDF]

open access: yesRenal Replacement Therapy, 2017
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.
Yoko Yoshida   +2 more
doaj   +2 more sources

Atypical hemolytic uremic syndrome: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2020
Background Thrombotic microangiopathy is a pathological condition comprised of microvascular thrombosis involving any organ of the body leading to thrombocytopenia, Coombs-negative hemolytic anemia, and end-organ damage.
B. M. D. B. Basnayake   +7 more
doaj   +3 more sources

Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome [PDF]

open access: yesAmerican Journal of Perinatology Reports, 2016
Précis Introduction Early diagnosis of atypical uremic–hemolytic syndrome may be challenging during the puerperium period. Correct diagnosis and timely management are crucial to improve outcomes.
Antonio F. Saad   +3 more
doaj   +3 more sources

COVID-19 vaccination and Atypical hemolytic uremic syndrome

open access: yesFrontiers in Immunology, 2022
IntroductionCOVID-19 vaccination has been associated with rare but severe complications characterized by thrombosis and thrombocytopenia.Methods and ResultsHere we present three patients who developed de novo or relapse atypical hemolytic uremic syndrome
Romy N. Bouwmeester   +6 more
doaj   +2 more sources

Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report. [PDF]

open access: yesImmun Inflamm Dis
The emergence of new SARS‐CoV‐2 variants and the global COVID‐19 pandemic spurred urgent vaccine development. While common vaccine side effects are well‐documented, rare adverse events necessitate post‐marketing surveillance.
Campos MAG   +4 more
europepmc   +2 more sources

The Path to Accessible Care: Development and Impact of Eculizumab Biosimilars for Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome. [PDF]

open access: yesBioDrugs
Eculizumab, a humanized monoclonal antibody targeting complement C5, is the first approved drug for complement-mediated diseases and indicated to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, myasthenia gravis, and ...
Jang JH   +4 more
europepmc   +2 more sources

A Case of Severe Pre‐Eclampsia Complicated by HELLP Syndrome and Extensive Hepatic Infarction

open access: yesClinical Case Reports
Extensive hepatic infarction is a rare but potentially fatal complication of HELLP syndrome and is often difficult to recognize because of nonspecific clinical manifestations.
Tiange Xia   +3 more
doaj   +2 more sources

Difficulties in diagnosing atypical hemolytic uremic syndrome [PDF]

open access: yesСибирский научный медицинский журнал, 2020
The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome (aHUS). aHUS is a disease characterized by an unfavorable prognosis (severe or catastrophic course with rapid development of terminal renal or multi ...
N. V. Fomina   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy